Nitric oxide and reactive oxygen species: Clues to target oxidative damage repair defective breast cancers

Area of Science:

• Oncology
• Biochemistry
• Molecular Biology

Background:

• Nitric Oxide (NO) and Reactive Oxygen Species (ROS) are key biomolecules in cancer.
• Their roles in tumorigenesis are concentration-dependent, exhibiting both pro- and anti-tumorigenic effects.
• NO and ROS show therapeutic potential by inducing apoptosis and sensitizing cancer cells.

Purpose of the Study:

• To review the dual role of NO and ROS in cancer progression and therapy.
• To investigate the potential of combinatorial therapy using NO donors and ROS inducers.
• To analyze the sensitization of triple-negative breast cancer cells to ROS inducers via NO donors.

Main Methods:

• Literature review on NO and ROS in cancer.
• Experimental analysis of combinatorial therapy using an NO donor (SNAP) and a ROS inducer.
• Focus on triple-negative breast cancer cells (HCC 1937) with defective oxidative damage repair.

Main Results:

• NO and ROS exhibit concentration-dependent, bimodal effects in cancer.
• Higher concentrations of NO and ROS can induce pro-apoptotic signals.
• NO donors can sensitize cancer cells, including those with DNA repair defects, to ROS-induced damage.

Conclusions:

• NO and ROS have significant, albeit complex, roles in cancer progression and therapy.
• Combinatorial therapy exploiting NO-mediated sensitization holds promise for anti-cancer strategies.
• Targeting oxidative damage repair pathways in conjunction with NO and ROS modulation is a viable therapeutic approach.